| KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. | |
| | |
MedLine Citation:
|
PMID: 23027075 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: The prognostic value of KRAS mutation in patients with colorectal cancer liver metastases (CLM) receiving neoadjuvant chemotherapy including bevacizumab before liver resection is unclear. METHODS: The KRAS and BRAF status of resected CLM was assessed in prospectively studied patients. Mutations were correlated with recurrence-free and overall survival. Only patients with remaining vital tumour cells in the resected specimen and those without disease progression were analysed; those with progressive disease did not undergo resection. RESULTS: A total of 60 patients were enrolled. Fifteen (25 per cent) had a KRAS mutation, but none of the 60 patients had a BRAF mutation. The radiological response to neoadjuvant chemotherapy including bevacizumab, assessed according to the Response Evaluation Criteria In Solid Tumours, was partial in 52 patients (87 per cent) and the remaining eight had stable disease. The partial response rate was similar in patients with a KRAS mutation and those with the wild-type gene (12 of 15 versus 40 of 45 patients; P = 0·400). KRAS mutation had a negative prognostic effect on recurrence-free survival (hazard ratio (HR) 2·48, 95 per cent confidence interval 1·26 to 4·89; P = 0·009) and overall survival (HR 3·51, 1·30 to 9·45; P = 0·013). CONCLUSION: This study provided further evidence for the prognostic importance of KRAS status in terms of recurrence-free and overall survival. Neoadjuvant chemotherapy including bevacizumab elicited a response, irrespective of KRAS status, in this selected group of patients with CLM. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd. |
| | |
Authors:
|
S Stremitzer; J Stift; B Gruenberger; D Tamandl; T Aschacher; B Wolf; F Wrba; T Gruenberger |
Related Documents
:
|
23607775 - Advanced hepatocellular carcinoma with lymph node metastases showing epithelial to mese... 11258775 - Significance of plasma cytokine levels in melanoma patients with histologically negativ... 7934065 - Total abdominal perfusion (tap) in the treatment of abdominal metastatic melanoma. 12079215 - A rational approach to the follow-up of melanoma patients. 17446005 - Distribution of brain metastases in relation to the hippocampus: implications for neuro... 21864925 - Treating intermediate-risk prostate cancer with hypofractionated external beam radiothe... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The British journal of surgery Volume: 99 ISSN: 1365-2168 ISO Abbreviation: Br J Surg Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-10-02 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372553 Medline TA: Br J Surg Country: England |
Other Details:
|
Languages: eng Pagination: 1575-82 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd. |
Affiliation:
|
Department of General Surgery, Medical University Vienna, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: External biliary drainage and liver regeneration after major hepatectomy.
Next Document: Criteria for drain removal following liver resection.